Age-stratified proteomic characteristics and identification of promising precise clinical treatment targets of colorectal cancer

• Published in: Journal of proteomics 2023-04, Vol.277, p.104863, Article 104863
• Main Authors: Wang, Qianqian, Zhou, Yuanchen, Zhou, Geyujia, Qin, Geng, Tan, Chang, Yin, Tengfei, Zhao, Dongyan, Yao, Shukun
• Format: Article
• Language: English
• Subjects: Colorectal cancer; Precise treatment targets; Precision oncology; Prognostic biomarker; Proteomics
• ISSN: 1874-3919
• DOI: 10.1016/j.jprot.2023.104863

Colorectal cancer (CRC) is an extremely lethal disease worldwide. However, the underlying pathogenesis remains unclear. This study aimed to reveal the distinct characteristics of age-stratified CRC at the protein level and explore precise treatment targets. Patients who underwent surgical removal with pathologically confirmed CRC at China-Japan Friendship Hospital from January 2020 to October 2021 were recruited, cancer and para-carcinoma tissues (> 5 cm) were detected by mass spectrometry. Ninety-six clinical samples were collected and divided into three groups according to age: young (≤ 50 years), middle-aged (51–69 years), and old (≥ 70 years). Quantitative proteomic analysis was performed, as well as comprehensive bioinformatic analysis based on the Human Protein Atlas, Clinical Proteomic Tumor Analysis Consortium and Connectivity Map databases. The numbers of upregulated and downregulated proteins were 1315 and 560 in the young group, 757 and 311 in the old group, and 1052 and 468 in the middle-aged group, respectively. Bioinformatic analysis showed that these differentially expressed proteins had different molecular functions and participated in extensive signaling pathways. We also revealed ADH1B, ARRDC1, GATM, GTF2H4, MGME1, and LILRB2 as possible cancer-promoting molecules, which might serve as potential prognostic biomarkers and precise therapeutic targets for CRC. This study comprehensively characterized the proteomic profiles of age-stratified colorectal cancer patients, focusing on the differentially expressed proteins between cancer and paracancerous tissues in different age groups, in an effort to find corresponding potential prognostic biomarkers and therapeutic targets. In addition, this study provides potentially valuable clinical small molecule inhibitory agents. [Display omitted] •The proteomic characteristics of colorectal cancer in different age groups were comprehensively disclosed.•Six novel differentially expressed proteins were identified as potential prognostic biomarkers and therapeutic targets.•Targeting LILRB2 might have the potential to improve the prognosis of patients with colorectal cancer.•Potential druggable protein targets of colorectal cancer and their corresponding small inhibitory agents were summarized.